West Houston Dermatology

Welcome to WHDERM - West Houston Dermatology

BLOG

Long Term Study of Pediatric Psoriasis Patients

Psoriasis Research

Medical researchers from both the University of California School of Medicine and Wake Forest University School of Medicine have conducted a long-term study of pediatric patients with psoriasis.  This study is unique because it spans 28 years and has an even balance of male and female patients.  Researchers are still drafting articles for peer-review, but some initial data is available.  The patients ranged from 8 to 18 years of age, and researchers considered data from some 3.8 million office visits.  It was found that 63% of pediatric patients during this 28 year period were treated with topical corticosteroids, with the most frequently prescribed psoriasis drugs being:  betamethasone, fluocinonide, diproprinate, and fluocinolone.  Further, the majority of office visits occurred in children between the ages of 13 to 18 years of age.  While there are many hypotheses of why this age group most frequently visited their dermatologist for psoriasis treatment, many speculate that the frequency of visits is directly related to the psychological component of psoriasis.  Active psoriasis can be public (depending upon where lesions erupt) and draw unwanted attention from people unfamiliar with the skin disease.  While this emotional component exists for nearly all psoriasis patients, teens are most often affected due to developing coping and life skills.  Though there is not presently a cure for psoriasis, numerous clinical trials and studies are going on to help people affected by the disease.  Even if your child has tried psoriasis treatment in Houston in the past without the desired results, please consider a consult at West Houston Dermatology.  Stephen Mahoney, M.D. is a national expert in treating psoriasis as well as other auto-immune skin diseases.